Total Payments
$439,798
2024 Payments
$108,417
Companies
33
Transactions
1,043
Medicare Patients
2,942
Medicare Billing
$404,751
Payment Breakdown by Category
Other$401,683 (91.3%)
Food & Beverage$16,700 (3.8%)
Travel$14,180 (3.2%)
Consulting$6,500 (1.5%)
Education$735.68 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $401,683 | 280 | 91.3% |
| Food and Beverage | $16,700 | 494 | 3.8% |
| Travel and Lodging | $14,180 | 252 | 3.2% |
| Consulting Fee | $6,500 | 11 | 1.5% |
| Education | $735.68 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $347,049 | 570 | $0 (2024) |
| Allergan, Inc. | $71,248 | 138 | $0 (2021) |
| Theravance Biopharma, Inc. | $15,031 | 51 | $0 (2018) |
| Smith+Nephew, Inc. | $885.83 | 65 | $0 (2024) |
| Organogenesis Inc. | $765.12 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $622.72 | 29 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $608.07 | 24 | $0 (2023) |
| Nuo Therapeutics | $500.00 | 1 | $0 (2017) |
| Insmed, Inc. | $480.42 | 15 | $0 (2024) |
| ViiV Healthcare Company | $401.01 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108,417 | 166 | ABBVIE INC. ($107,745) |
| 2023 | $73,375 | 127 | ABBVIE INC. ($72,784) |
| 2022 | $96,123 | 234 | ABBVIE INC. ($95,590) |
| 2021 | $74,595 | 159 | AbbVie Inc. ($70,864) |
| 2020 | $29,633 | 94 | Allergan, Inc. ($29,021) |
| 2019 | $18,217 | 92 | Allergan Inc. ($16,797) |
| 2018 | $18,412 | 79 | Allergan Inc. ($12,997) |
| 2017 | $21,025 | 92 | Theravance Biopharma Inc. ($10,617) |
All Payment Transactions
1,043 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/19/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ANTIFUNGALS | ||||||
| 12/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $350.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $174.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $105.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $31.60 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Pharma Products | ||||||
| 11/21/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $0.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $125.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $19.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $22.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $488.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $61.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 667 | 1,004 | $185,490 | $95,180 |
| 2022 | 7 | 697 | 1,040 | $182,870 | $90,541 |
| 2021 | 10 | 713 | 1,029 | $181,590 | $94,136 |
| 2020 | 9 | 865 | 1,397 | $246,006 | $124,893 |
Total Patients
2,942
Total Services
4,470
Medicare Billing
$404,751
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 208 | $41,600 | $20,210 | 48.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 180 | 275 | $34,375 | $17,842 | 51.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 107 | $27,285 | $15,215 | 55.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 43 | 119 | $23,800 | $13,960 | 58.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 97 | 98 | $24,500 | $10,470 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 108 | $18,900 | $8,626 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 21 | $4,200 | $3,107 | 74.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 30 | $5,250 | $3,101 | 59.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $3,600 | $1,751 | 48.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 22 | $1,980 | $898.26 | 45.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 218 | 415 | $52,005 | $24,417 | 47.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 138 | 202 | $40,400 | $17,126 | 42.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 100 | $25,500 | $16,433 | 64.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 116 | 120 | $30,000 | $13,467 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 82 | $14,350 | $6,705 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 26 | 44 | $8,800 | $5,349 | 60.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 22 | $4,400 | $3,215 | 73.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 29 | $5,075 | $2,996 | 59.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 26 | $2,340 | $834.78 | 35.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 165 | 241 | $45,125 | $21,094 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 342 | $42,750 | $20,954 | 49.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 102 | 103 | $26,265 | $17,448 | 66.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 107 | 114 | $28,500 | $13,235 | 46.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 88 | $15,400 | $7,542 | 49.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 31 | 51 | $10,200 | $6,438 | 63.1% |
About Dr. William Pace, MD
Dr. William Pace, MD is a Infectious Disease healthcare provider based in Southampton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114188893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Pace, MD has received a total of $439,798 in payments from pharmaceutical and medical device companies, with $108,417 received in 2024. These payments were reported across 1,043 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($401,683).
As a Medicare-enrolled provider, Pace has provided services to 2,942 Medicare beneficiaries, totaling 4,470 services with total Medicare billing of $404,751. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Southampton, PA
- Active Since 06/24/2008
- Last Updated 05/19/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1114188893
Products in Payments
- DALVANCE (Drug) $393,860
- VIBATIV (Drug) $15,054
- TEFLARO (Drug) $11,426
- AVYCAZ (Drug) $8,038
- NUZYRA (Drug) $608.07
- COLLAGENASE SANTYL (Drug) $556.48
- Aurix (Device) $500.00
- Arikayce (Drug) $480.42
- PREZCOBIX (Drug) $384.00
- OMNIGRAFT (Device) $288.74
- Puraply (Medical Supply) $272.35
- TRIUMEQ (Drug) $203.95
- Apligraf (Device) $203.02
- Santyl (Drug) $202.10
- Symtuza (Drug) $190.22
- SYMTUZA (Drug) $129.96
- Vibativ (Drug) $126.25
- INVOKANA (Drug) $124.07
- Apligraf (Biological) $124.00
- GRAFIX PL (Medical Supply) $113.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Southampton
Donald Marcus, M.d, M.D
Infectious Disease — Payments: $4,891
Infectious Disease $4,891
George Poporad, M.d, M.D
Infectious Disease — Payments: $4,096
Infectious Disease $4,096
Dr. Divya Sareen, M.d, M.D
Infectious Disease — Payments: $3,467
Infectious Disease $3,467
Dr. Richard Tepper, M.d, M.D
Infectious Disease — Payments: $2,043
Infectious Disease $2,043
Dr. Rajeev Fernando, M.d, M.D
Infectious Disease — Payments: $1,221
Infectious Disease $1,221
Dr. Angela Lawton, M.d, M.D
Infectious Disease — Payments: $719.06
Infectious Disease $719.06